Our systems are now restored following recent technical disruption, and we’re working hard to catch up on publishing. We apologise for the inconvenience caused. Find out more

Recommended product

Popular links

Popular links


Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders

Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders

Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders

Diagnosis and Management
Dag Aarsland , Stavanger University Hospital, Stavanger
Jeffrey Cummings , Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas
Daniel Weintraub , University of Pennsylvania
K. Ray Chaudhuri , King’s College Hospital, London
August 2013
Hardback
9781107039223

Looking for an inspection copy?

This title is not currently available for inspection.

£107.00
GBP
Hardback
USD
eBook

    Psychiatric and cognitive changes are common in patients with Parkinson's disease and have key clinical consequences but, despite this, these symptoms are often under-diagnosed and under-treated, leading to increased morbidity and costs. With chapters focused on the major neuropsychiatric features, Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders rectifies this deficit. Written by experts in the field, with a consistent focus on relevant clinical knowledge, it provides a comprehensive overview including all the major behavioral changes associated with movement disorders. The book provides broad, in-depth, accurate and up-to-date scientific information as well as crucial understanding and practical tools to help patients. The book is essential reading for clinicians working in neurology, psychiatry and geriatric medicine.

    • Brings to light often under-diagnosed issues
    • Has a consistent focus on relevant clinical knowledge
    • The only up-to-date book covering all behavioral problems related to movement diseases

    Reviews & endorsements

    'This is a first-rate book on the neuropsychiatry of Parkinson's disease. It should be required reading for clinicians who are involved in the treatment of patients with this illness.' Doody's Notes

    See more reviews

    Product details

    August 2013
    Hardback
    9781107039223
    307 pages
    252 × 193 × 22 mm
    0.9kg
    25 b/w illus. 5 colour illus. 51 tables
    Available

    Table of Contents

    • Preface
    • Part I. General Aspects:
    • 1. Overview of Parkinson's disease: epidemiology, diagnosis, course, medical and surgical management Sheila S. Rane and Christopher G. Goetz
    • 2. Parkinson's disease: pathology, anatomy, and behavior James B. Leverenz and Daniel J. Burdick
    • 3. Genetics and behavior and cognition in Parkinson's disease Caroline H. Williams-Gray and Roger A. Barker
    • 4. The boundaries of Parkinson's disease dementia and dementia with Lewy bodies Elisabet Londos
    • Part II. Diagnosis and Biomarkers:
    • 5. Cognitive assessment in Parkinson's disease Jaime Kulisevsky, Saül Martínez-Horta and Javier Pagonabarraga
    • 6. Clinical assessment: mood and motivation Albert F. G. Leentjens
    • 7. Imaging and behavior in Parkinson's disease: structural imaging Mona K. Beyer, Turi O. Dalaker and Liana G. Apostolova
    • 8. Imaging and behavior in Parkinson's disease: functional imaging Agneta Nordberg
    • 9. Diagnosis and biomarkers: CSF Brit Mollenhauer and Henrik Zetterberg
    • Part III. Specific Neuropsychiatric Disorders:
    • 10. Depression Per Svenningsson and Dag Aarsland
    • 11. Anxiety Laura Marsh and Jessica Calleo
    • 12. Apathy Kathy Dujardin
    • 13. Impulse control disorder Daniel Weintraub and Irena Rektorova
    • 14. Hallucinations and psychosis Oscar Bernal-Pacheco and Hubert H. Fernandez
    • 15. Early cognitive impairment Alexander I. Tröster and Dag Aarsland
    • 16. Parkinson's disease dementia: features and management BaÅŸar Bilgiç, HaÅŸmet A. HanaÄŸasi and Murat Emre
    • 17. Sleep disturbances Pouya Movahed, Kristina Røkenes Karlsen and K. Ray Chaudhuri
    • Part IV. Management:
    • 18. Parkinson's disease: drug treatment and behavior Jaime Kulisevsky, Javier Pagonabarraga and Carolina Villa-Bonomo
    • 19. Surgical treatments and behavior Jens Volkmann and Christine Daniels
    • 20. Clinical trials for psychotropic agents in Parkinson's diesase using psychosis as a model Ryan R. Walsh and Jeffrey Cummings
    • Part V. Other Issues:
    • 21. Clinical implications of neuropsychiatric symptoms in Parkinson's disease Angelo Antonini and Pablo Martinez-Martin
    • 22. Neuropsychiatric and cognitive disorders in other Parkinsonian disorders Adam Gerstenecker, Benjamin T. Mast and Irene Litvan
    • 23. Neuropsychiatric aspects of the on-off phenomenon Irene Rektorova and Marek Balaz
    • 24. Treatment of neuropsychiatric disturbances in Parkinson's disease: future prospects and strategies Jeffery Cummings and Dag Aarsland
    • Index.
      Contributors
    • Sheila S. Rane, Christopher G. Goetz, James B. Leverenz, Daniel J. Burdick, Caroline H. Williams-Gray, Roger A. Barker, Elisabet Londos, Jaime Kulisevsky, Saül Martínez-Horta, Javier Pagonabarraga, Albert F. G. Leentjens, Mona K. Beyer, Turi O. Dalaker, Liana G. Apostolova, Agneta Nordberg, Brit Mollenhauer, Henrik Zetterberg, Per Svenningsson, Dag Aarsland, Laura Marsh, Jessica Calleo, Kathy Dujardin, Daniel Weintraub, Irena Rektorova, Oscar Bernal-Pacheco, Hubert H. Fernandez, Alexander I. Tröster, BaÅŸar Bilgiç, HaÅŸmet A. HanaÄŸasi, Murat Emre, Pouya Movahed, Kristina Røkenes Karlsen, K. Ray Chaudhuri, Carolina Villa-Bonomo, Jens Volkmann, Christine Daniels, Ryan R. Walsh, Jeffrey Cummings, Angelo Antonini, Pablo Martinez-Martin, Adam Gerstenecker, Benjamin T. Mast, Irene Litvan, Marek Balaz

    • Editors
    • Dag Aarsland , Stavanger University Hospital, Stavanger

      Dag Aarsland MD is Head of Research, Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger and Professor of Geriatric Psychiatry, University of Oslo, School of Medicine, Oslo, Norway.

    • Jeffrey Cummings , Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas

      Jeffrey Cummings MD is Director of the Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada and Cleveland, OH, USA.

    • Daniel Weintraub , University of Pennsylvania

      Daniel Weintraub MD is Assistant Professor of Psychiatry at the University of Pennsylvania and Fellow at the University of Pennsylvania Institute of Aging, Philadelphia, PA, USA.

    • K. Ray Chaudhuri , King’s College Hospital, London

      Ray Chaudhuri MD is Consultant Neurologist and Professor in Neurology/Movement Disorders at King's College Hospital NHS Foundation Trust, London, UK.